OS Therapies Inc (OSTX) reporting calendar
OS Therapies Inc files periodic reports with the SEC as OSTX on NYSE. Atlas tracks 9 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 25 Jul 2026 – 7 Sep 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 18 May 2026
- Reports on record
- 9
How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 47 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open OSTX market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll NYSE reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 18 May 2026 | 48 days | 0001213900-26-058070 |
| 10-K | 31 Dec 2025 | 31 Mar 2026 | 90 days | 0001213900-26-036629 |
| 10-Q | 30 Sep 2025 | 14 Nov 2025 | 45 days | 0001213900-25-110829 |
| 10-Q | 30 Jun 2025 | 18 Aug 2025 | 49 days | 0001213900-25-077916 |
| 10-Q | 31 Mar 2025 | 15 May 2025 | 45 days | 0001213900-25-044336 |
| 10-K | 31 Dec 2024 | 31 Mar 2025 | 90 days | 0001213900-25-026238 |
| 10-Q | 30 Sep 2024 | 15 Nov 2024 | 46 days | 0001213900-24-098760 |
| 10-Q | 30 Jun 2024 | 14 Aug 2024 | 45 days | 0001213900-24-069063 |
| 10-Q | 31 Mar 2024 | 20 May 2024 | 50 days | 0001213900-24-045141 |
Source: SEC EDGAR company submissions for CIK 0001795091. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.